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ABSTRACT Membrane lysis caused by antibiotic peptides is often rationalized by means of two different models: the so-
called carpet model and the pore-forming model. We report here on the lytic activity of antibiotic peptides from Australian tree
frogs, Maculatin 1.1, Citropin 1.1, and Aurein 1.2, on POPC or POPC/POPG model membranes. Leakage experiments using
ﬂuorescence spectroscopy indicated that the peptide/lipid mol ratio necessary to induce 50% of probe leakage was smaller for
Maculatin compared with Aurein or Citropin, regardless of lipid membrane composition. To gain further insight into the lytic
mechanism of these peptides we performed single vesicle experiments using confocal ﬂuorescence microscopy. In these
experiments, the time course of leakage for different molecular weight (water soluble) ﬂuorescent markers incorporated inside of
single giant unilamellar vesicles is observed after peptide exposure. We conclude that Maculatin and its related peptides
demonstrate a pore-forming mechanism (differential leakage of small ﬂuorescent probe compared with high molecular weight
markers). Conversely, Citropin and Aurein provoke a total membrane destabilization with vesicle burst without sequential probe
leakage, an effect that can be assigned to a carpeting mechanism of lytic action. Additionally, to study the relevance of the
proline residue on the membrane-action properties of Maculatin, the same experimental approach was used for Maculatin-Ala
and Maculatin-Gly (Pro-15 was replaced by Ala or Gly, respectively). Although a similar peptide/lipid mol ratio was necessary to
induce 50% of leakage for POPC membranes, the lytic activity of Maculatin-Ala and Maculatin-Gly decreased in POPC/POPG
(1:1 mol) membranes compared with that observed for the naturally occurring Maculatin sequence. As observed for Maculatin,
the lytic action of Maculatin-Ala and Maculatin-Gly is in keeping with the formation of pore-like structures at the membrane
independently of lipid composition.
INTRODUCTION
A wide range of antibiotic peptides and toxins exert their
action by inducing alterations in the hydrophobic-hydrophilic
seal of cell membranes. The lytic effect is related to the
particular amino acid sequence of the peptide and the char-
acteristic composition of the membrane (1–8). Primarily, two
different mechanisms of membrane permeation or lysis have
been proposed: i), peptides that acquire a helix conformation
across the lipid bilayer and consequently form size-deﬁned
permeating structure named as pores (1,3,4,9); and ii), pep-
tides that remain tightly bound to the membrane interface
and promote bilayer damage via detergent-like or carpet-like
mechanism (2,5,7). Maculatin 1.1, Citropin 1.1, and Aurein
1.2 are antimicrobial chemically related peptides from
Australian tree frogs (see Table 1 for peptide amino acid
sequences). These peptides have antimicrobial activitymainly
against Gram positive bacteria (10–12). We recently demon-
strated the preferential interaction of Maculatin and Citropin
with anionic phospholipids by using the lipid monolayer
approach. It was proposed that these peptides adopt a helical
conformation at the interface (13). Additional data suggest
a pore-forming lytic behavior for the longer sequence
Maculatin and a carpeting mechanism for the shorter Citropin
(14–16). Maculatin, Citropin, and Aurein, mainly adopt an
a-helical conformation in model membrane environments
such as oriented lipid bicelles (17). To further characterize the
interaction of these peptides with membranes, we have
studied the lytic action ofMaculatin 1.1, Maculatin-Gly (Pro-
15 substituted by Gly), Maculatin-Ala (Pro-15 substituted by
Ala), Citropin 1.1, and Aurein 1.2 on lipid bilayers composed
of pure phospholipids and phospholipid mixtures by using
ﬂuorescence spectroscopy and confocal microscopy. Usually
the leakage experiments using ﬂuorescence spectroscopy of
carboxyﬂuorescein-ﬁlled large unilamellar vesicles (LUVs)
lack information about the mechanism leading to probe re-
lease. To gain a deeper insight about the lytic action of the
peptide we developed a novel experimental strategy that al-
lows direct tracking, using confocal microscopy, of giant
unilamellar vesicles (GUVs) ﬁlled with different molecular
weight (MW) and water soluble ﬂuorophores (Alexa488-
dextran 10,000 MW; Alexa546-maleimide or Alexa633-
maleimide, 1300 MW) (18). The real-time tracking of GUVs
ﬁlled with the different ﬂuorophores permits direct observa-
tion of the microscopic scenario and provides visual in-
formation that can be related to the leakage mechanism. The
combination of GUV technology and ﬂuorescence micros-
copy previously used to study lipid-lipid interactions (19,20)
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is used here to give new insights into lipid-peptide interactions
and lytic mechanisms.
MATERIAL AND METHODS
Materials
POPC (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine) and POPG
(1-palmitoyl-2-oleoyl-sn-glycero-3-[phospho-rac-(1-glycerol)]) were pur-
chased from Avanti Polar Lipids (Birmingham, AL) and were used without
further puriﬁcation. Maculatin 1.1, Maculatin-Gly, Maculatin-Ala (Pro-15
replaced by Gly or Ala, respectively), Citropin 1.1, and Aurein 1.2 were
synthesized by Mimotopes Pty (Melbourne, Australia) from L-amino acids
via standard N-a-Fmoc methods. The purity of the peptides, as judged by
high-pressure liquid chromatography and mass spectroscopy, was .90%.
The primary structure of the peptides is summarized in Table 1. 5,6-
Carboxyﬂuorescein was purchased from Eastman Kodak (Rochester, NY)
and Sigma Biochemicals (St. Louis, MO). DiI C18 (1,19-dioctadecyl-
3,3,39,39- tetramethylindocarbocyanine perchlorate), Alexa488-dextran,
Alexa543-maleimide, and Alexa633-maleimide were purchased from Molec-
ular Probes (Eugene, OR).
Preparation of carboxyﬂuorescein-loaded LUVs
Large unilamellar vesicles were prepared by freeze-thaw and extrusion
through polycarbonate ﬁlters (pore diameter 100 nm) (21) in an extrusion
device from Avestin (Ottawa, Canada). The method produces vesicles of
;93 nm according to light scattering measurements (22). Brieﬂy, carboxy-
ﬂuorescein 90-mM solution was generated by dissolving the proper amount
of the ﬂuorescent marker in Tris-HCl 20 mM, NaCl 150 mM, EDTA 1-mM
buffer (pH 7.4 adjusted with NaOH 1 M). A 10-mg/ml lipid (POPC or
POPC/POPG 1:1 mol ratio) solution in chloroform/methanol (2:1) was dried
under a stream of nitrogen followed by, at least, 4 h high vacuum drying.
The lipid ﬁlm was rehydrated with the carboxyﬂuorescein 90-mM buffer,
freeze-thawed for ﬁve cycles, and extruded 10 times. The free carboxy-
ﬂuorescein was removed by passing the liposome suspension through a
Sephadex G-100 column (Amersham-Pharmacia Biotech, Uppsala, Swe-
den). To ascertain the lipid concentration after the passing of the LUVs
through the column, phospholipid phosphorous was measured by the
modiﬁed microprocedure of Barlett (23).
Measure of carboxyﬂuorescein leakage
from LUVs
The release of carboxyﬂuorescein dye from the POPC or POPC/POPG
LUVs after peptide exposure was measured using SLM Aminco 4800C and
Spex Fluoromax-3 (Jovin Yvon Horiba, Tokyo, Japan) spectroﬂuorometers
at excitation and emission wavelengths of 480 and 510 nm, respectively.
Fluorescence intensity was continuously recorded after the desired amount
of peptide solution was added to a 1-ml cuvette (under continuous stirring)
containing the carboxyﬂuorescein-loaded LUVs. Leakage is expressed as
a percentage relative to the total amount of dye released by addition of 1% of
Triton X-100, which represented 100% leakage, as described by Weinstein
et al. (24). The error was ,5% (experiments were performed at least three
times). The experiments were performed maintaining the concentration of
osmotic active particles in the same proportion inside and outside
of vesicles. The time of presented release measuring was 5 min.
Preparation and visualization of GUVs
GUVs were prepared using the electroformation method, originally
developed by Angelova and Dimitrov (25,26). A homemade temperature-
controlled chamber was used as previously described (27,28). Brieﬂy, 3 ml
lipid stock solution (0.2 mg/ml in chloroform with or without the ﬂuorescent
probe DiIC18 0.5 mol%) was spread on each platinum electrode. The
chamber was then put into a vacuum chamber overnight to remove any re-
maining trace of organic solvent. Solutions of sucrose/Alexa488-dextran 1
mM/Alexa546-maleimide 10 mM, sucrose/Alexa488-dextran 1 mM/Alexa633-
maleimide 10 mM or sucrose/carboxyﬂuorescein 5 mM with an overall
osmolarity of 150 mOsM (measured with an Advanced Instruments model
3D3 osmometer, Norwood, MA) were equilibrated to temperatures above
the lipid phase transition and then added to the chamber covering the Pt
electrodes (0.4 ml ﬁnal volume). Immediately after buffer addition, the
platinum wires were connected to a function generator (Digimess FG 100)
and a low-frequency alternating ﬁeld (sinusoidal wave function with a
frequency of 10 Hz and amplitude of 1 V) was applied for 120 min. The AC
ﬁeld was turned off and the GUVs were harvested from the chamber. To
remove the ﬂuorescent solution from outside the vesicles, the GUVs were
washed several times in an iso-osmolar solution of glucose in 15-ml centri-
fuge tubes or passed through a Sephadex G-100 column.
Aliquots of GUVs suspended in glucose (0.3 ml) were added to an eight-
well plastic chamber (Lab-tek Brand Products, Naperville, IL). Due to the
density difference between the sugar solutions inside and outside the
vesicles the GUVs precipitate at the bottom of the chamber, which facilitates
observation in the inverted confocal microscope. The chamber was located
in an inverted confocal microscope (Zeiss LSM 510META, Jena, Germany)
for observation. The vesicles formed by this procedure had diameters
ranging from 15 to 50 mm. The excitation wavelengths were 488 nm (for
Alexa488-dextran and carboxyﬂuorescein), 543 nm (for Alexa546-maleimide
or DiI C18) and/or 633 nm (for Alexa633-maleimide). An iso-osmolar
solution of peptide was injected into the chamber (reaching a peptide/lipid
mol ratio of ;8) and a time-series scan was started to follow the peptide-
vesicle interaction. The experimental data are representative of at least three
experiments, where several vesicles were followed as a function of time after
peptide injection.
All leakage experiments were quantitatively analyzed using Metamorph
software by taking the change in ﬂuorescence intensity as the average gray
value measured for each micrograph of Alexa488-dextran and Alexa546-
maleimide inside GUVs after peptide exposure (18).
RESULTS
Carboxyﬂuorescein leakage from LUVs after
peptide exposure
The leakage of POPC LUVs ﬁlled with carboxyﬂuorescein,
after the vesicles were exposed to different peptide con-
centrations, is shown in Fig. 1. Undoubtedly the peptides
alter the hydrophobic/hydrophilic seal of LUV membranes
allowing permeation of carboxyﬂuorescein. As can be ob-
served in Fig. 1, Maculatin, Maculatin-Gly, and Maculatin-
Ala (peptide sequences are given in Table 1) result in 50%
dye leakage at a similar peptide/lipid mol ratio. However,
a slightly higher activity is evident for Maculatin-Ala with
POPC vesicles. Citropin and Aurein also provoke dye
TABLE 1 Peptide primary structure
Maculatin 1.1: GLFGVLAKVAAHVVPAIAEHF-NH2
Maculatin-Gly: GLFGVLAKVAAHVVGAIAEHF-NH2
Maculatin-Ala: GLFGVLAKVAAHVVAAIAEHF-NH2
Citropin 1.1: GLFDVIKKVASVIGGL-NH2
Aurein 1.2: GLFDIKKVASVIGGL-NH2
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leakage but the lipid/peptide mol ratio for 50% of car-
boxyﬂuorescein release was noticeably higher than that ob-
served for the Maculatin-related peptides (Fig. 1 A). Also,
Fig. 1 shows the lytic behavior of melittin, a well-known
lytic pore-forming peptide from bee venom, which was used
as a control. The peptide/lipid mol ratio obtained for 50% of
leakage induced by melittin is similar to that previously
reported by Go´mara et al. (29). We further observed that
melittin showed a decrease in the extent of leakage in POPC/
POPG composed LUVs compared with POPC LUVs (Fig.
1), which also was reported previously (29).
For LUVs composed of POPC/POPG (1:1 mol ratio) an
interesting difference in the lytic behavior of Maculatin
peptides was observed (Fig. 1 B). Even though the peptide/
lipid mol ratio to produce 50% of carboxyﬂuorescein leakage
for Maculatin was similar in POPC/POPG and POPC LUVs,
the ‘‘Pro-15 mutant’’ peptides (Table 1) have 10-fold lower
activities in the POPC/POPG (Fig. 1 B) mixture compare to
POPC membranes (Fig. 1 A). This feature points out the im-
portance of the Pro residue for the lytic action of the wild-type
Maculatin.
Aurein and Citropin, however, show a slight difference in
their lytic activity against LUV membranes composed of
either pure POPC or POPC/POPG lipid mixture (see Fig. 1).
Against anionic vesicles, the peptides seem to be a little less
active compared with POPC LUVs (Fig. 1). This difference
was also seen for the well-known highly cationic peptide
melittin (Fig. 1), but the difference was more pronounced
probably due to the presence of more positive charges for
this peptide (30,31). It is also interesting to note that Citropin
and Aurein peptides require a higher concentration in com-
parison with Maculatin peptides to affect the integrity of the
membrane.
Confocal microscopy of ﬂuorescently loaded
GUVs after peptide exposure
The incorporation of both ﬂuorophores, Alexa488-dextran
(MW 10,000) and Alexa546-maleimide (or Alexa633-malei-
mide; MW ; 1300), inside the GUVs is very useful to
directly observe the time course of any effect on membrane
permeability change (leakage of probes from inside of
GUVs; see Ambroggio et al. (18)). All the experiments were
carried out at a peptide/lipid mol ratio equivalent to obtain
100% of carboxyﬂuorescein release as described above
(.0.05; see Fig. 1). As control, in absence of peptide, the
ﬂuorescent content was not spontaneously released even
after 24 h of vesicle formation. The changes reported cor-
respond to single or several vesicles analyzed in a determined
optical ﬁeld. The overall effect in the vesicle population was
.90% for all peptides studied. It is necessary to remark that
the time analysis was obtained from experiments done in
a special chamber where it is not possible to perform con-
tinuous stirring (to allow rapid homogenization of the
peptide after injection) and the lag time before the leakage
start could be erroneously overestimated. Stirring inside
the chamber will generate movement of the GUVs and will
hamper the potential to perform time-series experiments on
single vesicles.
The effects of Maculatin, Maculatin-Gly, and Maculatin-
Ala on GUVs ﬁlled with the two ﬂuorescent markers are
shown in Fig. 2. As can be seen from the ﬂuorescent images,
when POPC GUVs are exposed to Maculatin peptides
(which have a longer amino acid sequence than Citropin and
Aurein; Table 1), the low molecular weight probe Alexa546-
maleimide ﬁrst leaked out of the vesicles without signiﬁcant
leakage of the high molecular weight probe Alexa488-
dextran. This last observation is conﬁrmed in a quantitative
manner in Fig. 3. Control experiments in the absence of
peptide are also given in the insert of Fig. 3 in which no
change in ﬂuorescence intensity was observed for a similar
period of time. Therefore, we exclude any signiﬁcant photo-
bleaching of the ﬂuorescent probes demonstrating that the
observed decrease in ﬂuorescence intensity is provoked by
the action of the peptides interacting with GUVs. The results
shown in Figs. 2 and 3 can be mechanistically interpreted as
being due to the presence of pore-like structures at the
membrane since the overall three-dimensional structure and
integrity of the GUVs are preserved after peptide exposure.
As controls, similar experiments were performed for the
FIGURE 1 Effect of antimicrobial peptides on LUVs permeability.
Percent of carboxyﬂuorescein release from LUVs after 5 min peptide
addition. Maculatin 1.1 (dotted circles), Maculatin-Gly (open circles),
Maculatin-Ala (solid circles), Citropin (solid squares), Aurein (open
squares), and melittin (triangles). (A) LUVs composed of POPC; (B) LUVs
composed of POPC/POPG (1:1 mol ratio). The peptide/lipid mol ratio was re-
ferred to the total amount in the cuvette of lipid and peptide (bound and un-
bound to LUVs).
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well-known pore-forming peptide melittin (supporting infor-
mation ﬁles), which exhibited similar results to those observed
for Maculatin peptides.
Fig. 4 shows the same experiments as described above but
for Citropin and Aurein. From these data it is clear that these
peptides have a different lytic behavior compared with those
observed for Maculatin peptides. GUVs exposed to Citropin
or Aurein were completely destroyed showing the simulta-
neous leakage of both dyes (no sequential).
To conﬁrm that the long-range membrane integrity was
not altered by the addition of pore-like forming peptides, the
DiIC18 probe was incorporated into GUVs as an indicator of
membrane bilayer structure. Fig. 5 shows micrographs of
POPC GUVs labeled with DiIC18 and loaded with Alexa
488-
dextran and Alexa633-maleimide. After Maculatin exposure
(Fig. 5 A) GUV’s membrane remains intact and the high
molecular weight probe is retained inside the vesicle,
conﬁrming the experimental observations shown in Fig. 2.
Conversely, when GUVs were exposed to either Aurein or
Citropin the membrane was completely disintegrated with
the simultaneous loss of ﬂuorescence from the three dyes
(complete membrane disruption; see Fig. 5 B).
A POPC GUV labeled with DiIC18 and loaded with
carboxyﬂuorescein is shown in Fig. 6. We observed that the
carboxyﬂuorescein probe experienced strong photobleach-
ing when it was irradiated continuously with the excitation
(laser) source (compare Fig. 6, A and B). As it is schematized
in Fig. 6 C there was not recovery of ﬂuorescence after
photobleaching conﬁrming the hydrophobic/hydrophilic
seal of the lipid bilayer. After addition of Maculatin, the
background was visible inside the vesicle (Fig. 6 D).
Photobleaching was not inducible after peptide addition,
indicating a bidirectional exchange of dye inside and outside
FIGURE 2 Direct visualization of lytic action by pore forming antimi-
crobial peptides. Confocal microscopy of POPC GUVs, ﬁlled with Alexa488-
dextran (green) and Alexa546-maleimide (red), exposed to Maculatin 1.1 5
mM. Time course of the effect of lipid-peptide interaction on bilayer
permeability after peptide addition. Left (green) and right (red) panels show
the differential leakage of the ﬂuorophores. (Top) 0 s, peptide addition;
(middle) 580 s, 50% Alexa546-maleimide ﬂuorescence intensity; (bottom)
670 s, ,1% Alexa546-maleimide ﬂuorescence intensity. The same behavior
was observed for either Maculatin-Gly or Maculatin-Ala 5 mM interacting
with POPC GUVs. See Fig. 3 for a clearer picture of the time course of dye
release. Scale bar, 32 mm.
FIGURE 3 Dye release kinetics from inside GUVs after the exposure to
antimicrobial peptides. Relative ﬂuorescence leakage from POPC GUVs
ﬁlled with Alexa488-dextran (squares) and Alexa546-maleimide (circles)
after exposure to 5 mM peptide of: Maculatin 1.1 (A, dotted symbols),
Maculatin-Gly (B, open symbols), and Maculatin-Ala (C, solid symbols).
The remaining ﬂuorescence intensity was determined in each micrograph
using Metamorph software to quantify the average gray value of Alexa488-
dextran and Alexa546-maleimide inside the GUVs after exposure to the
peptides. (A, insert) Control experiments: time-dependent ﬂuorescence
intensity in absence of peptide of Alexa488-dextran (squares) and Alexa546-
maleimide (circles) (see Materials and Methods).
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the vesicle (no loss of ﬂuorescence can be induced; compare
Fig. 6 D with Fig. 6 E). A similar effect was observed for
Maculatin-Ala, Maculatin-Gly, or melittin (Supplementary
Material).
DISCUSSION
The effect of antibiotic peptides on model membranes
has been widely reported in the literature. Two different
mechanisms of membrane lysis are generally accepted for
these peptides: the so-called carpet mechanism and the pore-
forming mechanism (1–5,7,9). From the results of ﬂuores-
cence experiments in cuvette, it is clear that all of the
peptides tested modify the permeability of POPC and POPC/
POPG bilayers (Fig. 1). Even though this information clearly
reﬂects a lytic action induced by the peptides studied, the
data do not provide direct information about any particular
lytic mechanism. Therefore, we developed a novel experi-
mental approach to allow observation of peptide-induced
differential leakage of different molecular-size ﬂuorescent
markers loaded into single vesicles (18). Previously,
Ladokhin et al. have described the differential release of
coencapsulated ﬂuorescent markers of different size from
LUVs using ﬂuorescence spectroscopy provoked by the
pore-forming melittin peptide (30). In our experiments, we
have been able to directly visualize differential release by
using confocal ﬂuorescence microscopy.
Citropin and Aurein peptides
GUVs are completely destroyed by addition of the shorter
sequence peptides, Citropin and Aurein. In these experi-
ments the ﬂuorescence intensity from both probes, regardless
of their molecular size, was instantly decreased to zero at
a speciﬁc time with simultaneous rupture of the membrane.
We attribute this behavior to the particular lytic mechanism,
i.e., the carpeting model. As proposed by Separovic and co-
workers, Citropin and Aurein may interact with the lipid
bilayer by partial insertion but their lengths do not allow
for complete spanning of the membrane with subsequent
formation of a pore-like structure (17). This partial insertion
model is reasonable because the short sequence peptides
cannot cross the bilayer due to the mismatch between the
bilayer thickness and the peptide length. Fluorescence experi-
ments in cuvettes indicate that, in contrast to the Maculatin
FIGURE 4 Direct visualization of lytic action by carpet mode induced by
antimicrobial peptides. Confocal microscopy of POPC GUVs, ﬁlled with
Alexa488-dextran (green) and Alexa546-maleimide (red), exposed to 5 mMof
Aurein. Time course of the effect of lipid-peptide interaction on membrane
permeability. (Top) Peptide addition, 0 s; (middle) partial damage, 1162 s;
(bottom) complete damage of GUVs, 1191 s). Left (green, high molecular
weight ﬂuorescent probe) and right (red, low molecular weight ﬂuorescent
probe). A similar behavior is observed for 5 mM of Citropin. Scale bar,
25 mm.
FIGURE 5 Direct visualization of membrane integrity after addition
of pore-like forming and carpet acting antimicrobial peptides. Confocal
microscopy of DiI-C18 containing POPC GUVs ﬁlled with Alexa488-
dextran (green) and Alexa633-maleimide (blue), exposed to 5 mM of:
Maculatin 1.1 (A; a similar behavior was observed for either Maculatin-Ala
or Maculatin-Gly), Citropin (B; a similar behavior was observed for Aurein).
Effect of lipid-peptide interaction from the time, 0 s (from top to bottom)
after injection of the peptide. Left (green) and middle (blue) panels show the
differential leakage of the ﬂuorophores. Right (red) panel shows that the
membrane shape is not altered during the leakage process by the Maculatin
peptides (A). In contrast, panel B shows the complete disintegration of
several vesicles after peptide addition. Scale bar, 95 mm.
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peptides, a high peptide/lipid ratio is needed for Aurein
and Citropin to achieve dye leakage. This fact leads us to
speculate that the amount of peptide molecules required to
form a critical structure to disrupt the membrane is larger for
peptides acting in the carpeting mode than for those peptides
that are lytic by a pore-like mechanism (if similar partition
coefﬁcients are considered).
Maculatin peptides
From the studies carried out with the Maculatin natural
occurring sequence or with its mutants, we conclude that the
peptides induce an alteration in the permeation properties of
the GUV membranes, most likely by a pore-forming mech-
anism. This fact was clearly demonstrated using confocal
microscopy studies, and was reﬂected by the rapid loss in
ﬂuorescence intensity of the small molecular weight ﬂuo-
rescent probe whereas the ﬂuorescence intensity from the
high molecular weight probe trapped within the GUVs re-
mained almost constant (Fig. 2). Importantly, a similar
behavior to that observed for Maculatin was obtained when
ﬂuorescently labeled GUVs were exposed to the pore-
forming melittin peptide in agreement with previously
reported data obtained from other techniques for this peptide
(29,30). Our data also show that the shape of the GUV and
the long-range membrane organization do not seem to be
altered when pores are formed by Maculatin and its related
peptides, indicating a metastable peptide-lipid interaction
when these peptides are inserted into the membrane. Also,
the diameter of the GUVs was not substantially altered after
peptide interaction (as it can be appreciated in Fig. 2 or Fig.
5). As reported previously for other lytic peptides, peptide
insertion into the membrane, and consequent pore formation,
can induce alterations in the elastic properties of the
membrane or changes in membrane order (32–35). Although
our results do not provide information about the mechanical
properties or lateral order of the lipid membrane, we believe
that such changes ought to occur during pore formation to
compensate for peptide insertion, resulting in a similar three-
dimensional structure of the GUVs after peptide addition.
Additionally, as illustrated in Fig. 6, we observed that laser-
induced photobleaching of the dye inside the GUVs was
only possible before peptide addition, which indicates a
relative fast bidirectional ﬂow of the probe throughout the
pores (i.e., no photobleaching was possible after peptide
exposure indicating the simultaneous in and out ﬂow of the
dye through the membrane).
An interesting point is that Maculatin has similar lytic
activity (translated into a comparable peptide/lipid mol ratio)
when LUVs are composed of either POPC or POPC/POPG
but when Pro-15 is replaced by Gly or Ala, the lytic potency
is signiﬁcantly reduced in anionic vesicles. This character-
istic suggests that proline in the Maculatin sequence should
play a key role in the antibiotic activity allowing the peptide
to adopt an optimal amphiphilic conformation at the interface
leading to membrane damage (15,36). A slight difference in
the leakage of carboxyﬂuorescein-loaded POPC LUVs was
observed for the Maculatin-Ala peptide, which was slightly
more active than the Gly-15 mutant. This enhanced activity
can be due to the more hydrophobic nature of the Ala (com-
pared with Gly) or, possibly, reﬂects subtle changes in
peptide conformation at the interface. Additionally Gly sub-
stitution can provoke a more ﬂexible structure and for this
reason the peptide may lose its optimal amphiphilic conﬁgu-
ration when interacting with membranes.
In summary, we have directly visualized differences in
the two models of lytic action of antibiotic peptides pro-
posed by several authors (1–9). The disparity in the length
of the peptide sequence (assuming 1.5 A˚ per residue when
the peptide is adopting an ideal a-helical structure, see
Ambroggio et al. and others (13,18), a ﬂuid lipid bilayer has
an average hydrophobic width of ;40 A˚ see Hristova and
White (37) and the appropriate amphiphilicity may be the
reason for this difference. The longer sequence peptides are
able to adopt a transbilayer conﬁguration allowing probably
for peptide oligomerization at the interface and, conse-
quently, the formation of pore-like structures, preserving the
bilayer shape. Although the shorter sequence peptides are
able to interact with the membrane, there is a mismatch
between the peptide length and the bilayer thickness, which
FIGURE 6 Bidirectional ﬂux of carboxyﬂuorescein in
POPC GUVs after exposure to pore-like forming antimi-
crobial peptides. Confocal microscopy of DiI-C18 labeled
POPC GUVs, ﬁlled with carboxyﬂuorescein 5 mM before
(A), and after (D) exposure to Maculatin 1.1 or Maculatin-
Gly or Maculatin-Ala 5 mM. Immediate recovery of
ﬂuorescence background after site-directed carboxyﬂuor-
escein photobleaching (induced by the laser in the
microscope) in the interior of the vesicle after exposure
to the Maculatin peptides (D and E). (Control) GUVs that
were not exposed to the peptides do not recover the
ﬂuorescence background (C) after site-directed photo-
bleaching of carboxyﬂuorescein in the GUV interior (B). A
similar behavior was observed for 5 mM of Maculatin-Ala,
Maculatin-Gly, and melittin. Scale bar, 10 mm.
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prevents pore formation but leads to membrane destabiliza-
tion.
Finally, our experimental strategy can aid in the deter-
mination of the average pore size by using a series of dif-
ferent molecular weight probes. Experiments are in progress
within our lab to address this issue.
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